ProCE Banner Activity

Biomarker Testing in Prostate Cancer: An Essential Component in Transforming Care

PDF

Download this infographic developed by an expert pathologist featuring a clinical algorithm of germline genetic and somatic genomic testing for gene mutations in homologous recombination and mismatch repair pathways to guide optimal treatment decisions in advanced prostate cancer.

Released: March 14, 2024

Expiration: March 13, 2025

Share

Faculty

Scott A. Tomlins

Scott A. Tomlins, MD, PhD

Adjunct Associate Professor
Department of Pathology and Urology
University of Michigan Medical School
Ann Arbor, Michigan

Provided by

Provided by Clinical Care Options, LLC in partnership with the American Society for Clinical Pathology

ProCE Banner

Supporters

Supported by an educational grant from Pfizer, Inc.

Pfizer, Inc.

Partners

American Society for Clinical Pathology

ProCE Banner

Disclosure

Primary Author

Scott A. Tomlins, MD, PhD

Adjunct Associate Professor
Department of Pathology and Urology
University of Michigan Medical School
Ann Arbor, Michigan

Scott A. Tomlins, MD, PhD: consultant/advisor/speaker: Astellas; researcher (paid to institution): Astellas; royalties or patent beneficiary: Hologic/Ventana, Lynx Dx; individually publicly traded stocks/stock options: Aclys Bio, Strata Oncology; employee: Strata Oncology.